Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Cash Flow Reinvestment Rate
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Cash Flow Reinvestment Rate of 1.83x as of September 2025, reinvesting CN¥72.46 Million (capex CN¥72.46 Million ) from operating cash flow of CN¥39.68 Million. See 002653 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see 002653 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Xizang Haisco Pharmaceutical Group Co Ltd. See Xizang Haisco Pharmaceutical Group Co Lt (002653) flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.63x | CN¥494.23 Million | CN¥786.00 Million | CN¥331.98 Million | ▼ -49.3% |
| 2024 | 1.24x | CN¥548.28 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -28.0% |
| 2023 | 1.72x | CN¥774.20 Million | CN¥449.58 Million | CN¥391.01 Million | ▼ -81.1% |
| 2022 | 9.09x | CN¥859.79 Million | CN¥94.55 Million | CN¥700.17 Million | ▼ -78.1% |
| 2021 | 41.47x | CN¥1.48 Billion | CN¥35.80 Million | CN¥702.94 Million | ▲ +879.6% |
| 2020 | 4.23x | CN¥873.05 Million | CN¥206.21 Million | CN¥601.72 Million | ▲ +440.7% |
| 2019 | 0.78x | CN¥598.43 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -10.4% |
| 2018 | 0.87x | CN¥413.11 Million | CN¥472.61 Million | CN¥351.98 Million | ▼ -31.4% |
| 2017 | 1.27x | CN¥499.13 Million | CN¥391.81 Million | CN¥393.26 Million | ▲ +135.2% |
| 2016 | 0.54x | CN¥221.61 Million | CN¥409.20 Million | CN¥208.24 Million | ▼ -18.7% |
| 2015 | 0.67x | CN¥295.16 Million | CN¥443.03 Million | CN¥283.68 Million | ▲ +42.6% |
| 2014 | 0.47x | CN¥234.86 Million | CN¥502.57 Million | CN¥234.86 Million | ▲ +62.0% |
| 2013 | 0.29x | CN¥163.98 Million | CN¥568.41 Million | CN¥163.98 Million | ▲ +7.0% |
| 2012 | 0.27x | CN¥125.30 Million | CN¥464.75 Million | CN¥125.30 Million | ▼ -40.3% |
| 2011 | 0.45x | CN¥117.72 Million | CN¥260.79 Million | CN¥117.72 Million | ▲ +104.9% |
| 2010 | 0.22x | CN¥80.95 Million | CN¥367.38 Million | CN¥80.95 Million | ▲ +237.9% |
| 2009 | 0.07x | CN¥24.01 Million | CN¥368.21 Million | CN¥24.01 Million | ▼ -83.5% |
| 2008 | 0.40x | CN¥37.38 Million | CN¥94.45 Million | CN¥37.38 Million | — |